MX2022013879A - Selección por inserción génica en genes esenciales. - Google Patents

Selección por inserción génica en genes esenciales.

Info

Publication number
MX2022013879A
MX2022013879A MX2022013879A MX2022013879A MX2022013879A MX 2022013879 A MX2022013879 A MX 2022013879A MX 2022013879 A MX2022013879 A MX 2022013879A MX 2022013879 A MX2022013879 A MX 2022013879A MX 2022013879 A MX2022013879 A MX 2022013879A
Authority
MX
Mexico
Prior art keywords
knock
essential gene
coding sequence
essential
sequence
Prior art date
Application number
MX2022013879A
Other languages
English (en)
Inventor
John Anthony Zuris
Chew-Li Soh
Mark James Tomishima
Conor Brian Mcauliffe
Carrie Marie Margulies
Peter Tonge
Claudio Monetti
Original Assignee
Editas Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Editas Medicine Inc filed Critical Editas Medicine Inc
Publication of MX2022013879A publication Critical patent/MX2022013879A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/11—Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Estrategias, sistemas, composiciones y métodos para la producción eficaz de clones celulares con inserción génica sin genes indicadores. Un gen esencial se establece como diana usando un casete de inserción génica que comprende una secuencia de codificación exógena de un producto génico de interés (o "secuencia de carga") en marco con y cadena abajo (3') de una secuencia de codificación exógena o una secuencia de codificación parcial del gen esencial. Los eventos de direccionamiento no deseados crean una versión no funcional del gen esencial, en esencia una inactivación (¿knock out¿), que se "rescata" mediante la integración correcta del casete de inserción génica, que restaura la región de codificación del gen esencial para que se produzca un producto génico funcional y coloca la secuencia de carga en marco con y cadena abajo de la secuencia de codificación del gen esencial.
MX2022013879A 2020-05-04 2021-05-04 Selección por inserción génica en genes esenciales. MX2022013879A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063019950P 2020-05-04 2020-05-04
PCT/US2021/030744 WO2021226151A2 (en) 2020-05-04 2021-05-04 Selection by essential-gene knock-in

Publications (1)

Publication Number Publication Date
MX2022013879A true MX2022013879A (es) 2023-02-01

Family

ID=78468371

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022013879A MX2022013879A (es) 2020-05-04 2021-05-04 Selección por inserción génica en genes esenciales.

Country Status (11)

Country Link
US (2) US20230227856A1 (es)
EP (1) EP4146813A2 (es)
JP (1) JP2023524976A (es)
KR (1) KR20230029603A (es)
CN (1) CN115916968A (es)
AU (1) AU2021267334A1 (es)
BR (1) BR112022022384A2 (es)
CA (1) CA3182286A1 (es)
IL (1) IL297881A (es)
MX (1) MX2022013879A (es)
WO (1) WO2021226151A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11661459B2 (en) 2020-12-03 2023-05-30 Century Therapeutics, Inc. Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
EP4263600A1 (en) 2020-12-18 2023-10-25 Century Therapeutics, Inc. Chimeric antigen receptor systems with adaptable receptor specificity
TW202400252A (zh) 2022-04-28 2024-01-01 美商藍岩醫療公司 用於安全基因組整合之新位點及其使用方法
WO2023220206A2 (en) * 2022-05-10 2023-11-16 Editas Medicine, Inc. Genome editing of b cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015345979A1 (en) * 2014-11-10 2017-06-01 Murdoch Childrens Research Institute Vectors and methods for targeted integration in loci comprising constitutively expressed genes
CN109415687A (zh) * 2016-04-07 2019-03-01 蓝鸟生物公司 嵌合抗原受体t细胞组合物
EP3652312A1 (en) * 2017-07-14 2020-05-20 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites

Also Published As

Publication number Publication date
US20240117383A1 (en) 2024-04-11
US20230227856A1 (en) 2023-07-20
EP4146813A2 (en) 2023-03-15
CN115916968A (zh) 2023-04-04
AU2021267334A1 (en) 2022-12-22
KR20230029603A (ko) 2023-03-03
IL297881A (en) 2023-01-01
JP2023524976A (ja) 2023-06-14
WO2021226151A3 (en) 2021-12-02
WO2021226151A2 (en) 2021-11-11
CA3182286A1 (en) 2021-11-11
BR112022022384A2 (pt) 2022-12-13

Similar Documents

Publication Publication Date Title
MX2022013879A (es) Selección por inserción génica en genes esenciales.
MX2020005790A (es) Vectores de adn de extremo cerrado que pueden obtenerse de síntesis libre de células y un proceso para obtener vectores de ceadn.
MX2023003527A (es) Metodos y composiciones para mejorar atributos de plantas.
WO2018209320A8 (en) APTAZYME-INCORPORATED GUIDED RNA FOR USE WITH CRISPR-CAS9 IN THE GENOME EDITION AND TRANSCRIPTIONAL ACTIVATION
PH12020550484A1 (en) Methods and compositions for improving engineered microbes that fix nitrogen
MX2022007427A (es) Composiciones y metodos para alterar la floracion y arquitectura de planta para mejorar el potencial de rendimiento.
MX2020004344A (es) Objetivos genéticos para el direccionamiento de fijación de nitrógeno para mejorar los rasgos de las plantas.
MX2023006566A (es) Sistemas crispr tipo v clase 2 diseñados por ingeniería.
NZ756132A (en) Method for producing multispecific antibodies
MX2021015254A (es) Metodos para producir plantas con desarrollo de frutas alteradas y plantas derivas de las mismas.
MX2022011039A (es) Sistemas crispr clase ii tipo v.
WO2021257730A3 (en) Cells modified by a cas12i polypeptide
EA201891919A1 (ru) Способы трансфекции растений и сокращения событий случайной интеграции
AU2018274709A1 (en) Methods for increasing grain productivity
MY194187A (en) Promoter system inducing expression by 3-hydroxypropionic acid and method for biological production of 3-hydroxypropionic acid using same
MX2021003021A (es) Polipéptidos insecticidas mutantes de av3 y métodos para producción y uso de los mismos.
MX2022001893A (es) Alteracion de los rasgos de sabor en los cultivos de consumo mediante la desactivacion del sistema de mirosinasa/glucosinolato.
PH12021550256A1 (en) Novel crispr-associated protein and use thereof
MY169049A (en) Microorganisms for producing putrescine and process for producing putrescine using them
WO2023220206A3 (en) Genome editing of b cells
WO2018229521A8 (en) ENHANCED GENE EDITION
MX2020010718A (es) Composiciones y metodos para el trasplante de celulas madre.
ATE417116T1 (de) Chromosomstellen zur stringenten kontrolle von genaktivität durch transkriptionsteuersysteme
WO2021146666A3 (en) Tunable transposon systems
AU2017248848A1 (en) Enhanced gene delivery methods